MRC Center for Reproductive Health, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, UK.
Acta Obstet Gynecol Scand. 2019 May;98(5):545-549. doi: 10.1111/aogs.13560. Epub 2019 Feb 27.
Ovarian tissue cryopreservation has developed rapidly from its origins in experiments in sheep in the 1990s, and is now becoming recognized as a standard, rather than experimental, procedure. This review summarizes the origins of the technique, and key milestones in its development since the first reported sheep pregnancy in 1994 to the first successful human pregnancy in 2004, and now to the first baby born following cryopreservation of prepubertal ovarian tissue. Many challenges remain to optimize this technique, to improve the survival of follicles within the reimplanted ovarian tissue, to improve its reproducibility and hence the success rate and the lifespan of the graft. The other key area remains the possibility of the grafted tissue containing malignant cells, most importantly in leukemia.
卵巢组织冷冻保存技术从 20 世纪 90 年代在绵羊身上进行的实验开始迅速发展,现在已被认为是一种标准而非实验性的程序。本综述总结了该技术的起源,以及自 1994 年首例绵羊妊娠报道以来的发展中的关键里程碑,到 2004 年首例人类妊娠成功,以及现在首例经青春期前卵巢组织冷冻保存后出生的婴儿。为了优化这项技术,提高再植入卵巢组织内卵泡的存活率,提高其可重复性,从而提高成功率和移植物的寿命,仍有许多挑战需要克服。另一个关键领域仍然是移植物中是否含有恶性细胞的可能性,在白血病中尤为重要。